Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • Study on the Safety and Tolerability of TransCon IL-2 β/γ, Pembrolizumab, and Chemotherapy in Adults with Advanced or Metastatic Solid Tumors

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Belgium Italy Poland Spain
  • Study of BMS-986288 and Nivolumab for Patients with Advanced Solid Tumors

    Not recruiting

    2 1 1 1
    France Italy Spain
  • Study of Pembrolizumab for Patients with Advanced Solid Tumors

    Not recruiting

    2 1 1 1
    Investigated drugs:
    Denmark France Germany Italy The Netherlands Norway +3
  • Study of Olaparib for Patients with Advanced Cancer Having HRRm or HRD Mutations

    Not recruiting

    2 1 1
    Investigated drugs:
    Denmark France Ireland Italy Romania Spain
  • Study of MK-1088 and Pembrolizumab for Patients with Advanced Solid Tumors

    Not recruiting

    2 1 1 1
    Investigated drugs:
    Denmark
  • Study of CFT1946 alone and with trametinib or cetuximab in patients with BRAF-V600 mutant solid tumors who have received standard treatment

    Not recruiting

    2 1 1 1
    France Germany Italy Spain
  • Study of BMS-986408 Alone or with Nivolumab and Ipilimumab for Patients with Advanced Solid Tumors

    Not recruiting

    2 1 1 1
    France Spain
  • Study of NGM707 and Pembrolizumab for Patients with Advanced or Metastatic Solid Tumors

    Not recruiting

    2 1 1
    Investigated drugs:
    France Italy Spain
  • Study of BMS-986442 and Nivolumab, Alone or with Chemotherapy, for Patients with Advanced Solid Tumors and Non-Small Cell Lung Cancer

    Not recruiting

    2 1 1 1
    Italy Poland Spain
  • Study of Olaparib and Pembrolizumab for Patients with Advanced Cancer with HRRm or HRD Mutations

    Not recruiting

    2 1 1 1
    Investigated drugs:
    France Germany Italy Latvia Poland Romania +2